← Back to Search

CGM for Postpartum Diabetes Management

N/A

Recruiting

Led By Andrea Greiner, MD

Research Sponsored by Andrea L. Greiner

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up postpartum admission, 2-4 days

Awards & highlights

Study Summary

This trial will compare two methods of testing for hypoglycemia in postpartum patients: continuous monitoring vs traditional testing.

Who is the study for?

This trial is for women in their third trimester of pregnancy who are hospitalized and have type 1 or type 2 diabetes. They must own a smart device compatible with the CGM device. It's not for those under 18, non-English speakers, patients with gestational diabetes, allergies to adhesives, or skin conditions preventing sensor adherence.Check my eligibility

What is being tested?

The study is testing if using continuous glucose monitoring (CGM) right after childbirth can better detect low blood sugar levels compared to standard finger-prick tests in women with pre-existing diabetes.See study design

What are the potential side effects?

Potential side effects from using CGM may include skin irritation or allergic reactions due to the adhesive used to attach the sensor.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ postpartum admission, 2-4 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~postpartum admission, 2-4 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and postpartum admission, 2-4 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Glucose values

Trial Design

1Treatment groups

Experimental Treatment

Group I: CGMExperimental Treatment1 Intervention

A CGM device (Dexcom sensor and transmitter) will be placed by research personnel upon presentation to Labor and Delivery unit.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

CGM

2013

N/A

~1010

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Andrea L. GreinerLead Sponsor

Andrea Greiner, MDPrincipal InvestigatorUniversity of Iowa OBGYN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment open to minors for this research project?

"This clinical trial has a strict age boundary of 18 to 50. Thus, any participants younger or older than this range will be excluded from the research."

Answered by AI

Who is authorized to join in this experiment?

"Candidates should be between 18 and 50 years old, and must have a documented diagnosis of diabetes. The recruitment goal for this project is approximately 40 participants."

Answered by AI

How many participants are being treated in this research endeavor?

"Affirmative. Per information hosted on the clinicaltrials.gov web portal, this medical trial is actively recruiting candidates and has been since June 1st 2021. Up to 40 patients must be sourced from one location before the completion of this study which was most recently revised on November 20th 2023."

Answered by AI

Are there still vacancies for participants in this research endeavor?

"Affirmative. Clinicaltrials.gov holds the record that since it was first posted on June 1st 2021, this clinical trial has continued to actively seek out candidates. It is in need of 40 volunteers from one medical centre."

Answered by AI

Recent research and studies

Diabetes CareJournal

Reducing Inpatient Hypoglycemia in the General Wards Using Real-time Continuous Glucose Monitoring: The Glucose Telemetry System, a Randomized Clinical Trial

Singh, Lakshmi G., Medha Satyarengga, Isabel Marcano, William H. Scott, Lillian F. Pinault, Zhaoyong Feng, John D. Sorkin, Guillermo E. Umpierrez, and Elias K. Spanakis. 2020. “Reducing Inpatient Hypoglycemia in the General Wards Using Real-time Continuous Glucose Monitoring: The Glucose Telemetry System, a Randomized Clinical Trial”. Diabetes Care. American Diabetes Association. doi:10.2337/dc20-0840.

clinicaltrials.govStudy

Does the Use of Continuous Glucose Monitoring (CGM) in the Immediate Postpartum Period in Women With Pregestational Diabetes Admitted to the Hospital Decrease Hypoglycemic Episodes

Andrea L. Greiner 2021. "Does the Use of Continuous Glucose Monitoring (CGM) in the Immediate Postpartum Period in Women With Pregestational Diabetes Admitted to the Hospital Decrease Hypoglycemic Episodes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06141941.